Detailed information for compound 354045
Basic information
Technical information
- Name: Unnamed compound
- MW: 255.333 | Formula: C12H17NO3S
-
H donors: 2
H acceptors: 2
LogP: -0.89
Rotable bonds: 7
Rule of 5 violations (Lipinski): 1 - SMILES: COc1cccc(c1)CSCCC(C(=O)O)N
- InChi: 1S/C12H17NO3S/c1-16-10-4-2-3-9(7-10)8-17-6-5-11(13)12(14)15/h2-4,7,11H,5-6,8,13H2,1H3,(H,14,15)
- InChiKey: WAUOPBRKRQFQTA-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
No synonyms found for this compound
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Mus musculus | calcium channel, voltage-dependent, alpha2/delta subunit 1 | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
| Species | Potential target | Known druggable target/s | Ortholog Group |
|---|---|---|---|
| Echinococcus granulosus | voltage dependent calcium channel subunit | Get druggable targets OG5_133164 | All targets in OG5_133164 |
| Echinococcus multilocularis | voltage dependent calcium channel subunit | Get druggable targets OG5_133164 | All targets in OG5_133164 |
By sequence similarity to non orthologous known druggable targets
| Species | Potential target | Known druggable target | Length | Alignment span | Identity |
|---|---|---|---|---|---|
| Echinococcus granulosus | voltage dependent calcium channel subunit | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 1103 aa | 1025 aa | 23.3 % |
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus multilocularis | carbonic anhydrase II | 0.0248 | 0.4344 | 0.1907 |
| Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0193 | 0.2773 | 0.6383 |
| Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0248 | 0.4344 | 0.5 |
| Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0248 | 0.4344 | 0.5 |
| Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0248 | 0.4344 | 1 |
| Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0248 | 0.4344 | 0.5 |
| Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0248 | 0.4344 | 1 |
| Trypanosoma brucei | carbonic anhydrase-like protein | 0.0248 | 0.4344 | 0.5 |
| Schistosoma mansoni | hypothetical protein | 0.0104 | 0.0192 | 0.0442 |
| Echinococcus granulosus | carbonic anhydrase II | 0.0248 | 0.4344 | 0.1907 |
| Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0248 | 0.4344 | 0.5 |
| Schistosoma mansoni | serine-rich repeat protein | 0.0104 | 0.0192 | 0.0442 |
| Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0443 | 1 | 1 |
| Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0248 | 0.4344 | 0.5 |
| Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0248 | 0.4344 | 0.5 |
| Leishmania major | carbonic anhydrase-like protein | 0.0248 | 0.4344 | 0.5 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| Ki (binding) | = -6.29 | Displacement of [3H]L-leucine from alpha2delta containing calcium channel in murine brain | ChEMBL. | 16380257 |
| Ki (binding) | = 510 nM | Displacement of [3H]L-leucine from alpha2delta containing calcium channel in murine brain | ChEMBL. | 16380257 |
| Ki (binding) | = 510 nM | Displacement of [3H]L-leucine from alpha2delta containing calcium channel in murine brain | ChEMBL. | 16380257 |
| Log Ki (binding) | = -6.29 | Displacement of [3H]L-leucine from alpha2delta containing calcium channel in murine brain | ChEMBL. | 16380257 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
No external resources registered for this compound
Bibliographic References
1 literature reference was collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.